Evidence map›Paper›PMID 39070250›Full record

ArticleRSC advances2024

Towards combining backbone and sugar constraint in 3'-3' bis-phosphonate tethered 2'-4' bridged LNA oligonucleotide trimers.

Edouard Duchamp, Guillermo Vasquez, Neda Firoozi, Graeme C Freestone, Michael Oestergaard, Punit P Seth, Stephen Hanessian

Abstract read
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Stapling of β-Glucans Increases Antibody Binding.Journal of the American Chemical Society · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Edouard DuchampDepartment of Chemistry, Université de Montréal Québec H3C 3J7 Canada stephen.hanessian@umontreal.ca.
Guillermo VasquezDepartment of Medicinal Chemistry, Ionis Pharmaceuticals Carlsbad CA 92010 USA.
Neda FirooziDepartment of Chemistry, Université de Montréal Québec H3C 3J7 Canada stephen.hanessian@umontreal.ca.
Graeme C FreestoneDepartment of Medicinal Chemistry, Ionis Pharmaceuticals Carlsbad CA 92010 USA.
Michael OestergaardDepartment of Medicinal Chemistry, Ionis Pharmaceuticals Carlsbad CA 92010 USA.
Punit P SethAlnylam Pharmaceuticals 675 West Kendall St Cambridge MA 0214 USA.
Stephen HanessianDepartment of Chemistry, Université de Montréal Québec H3C 3J7 Canada stephen.hanessian@umontreal.ca.ORCID https://orcid.org/0000-0003-3582-6972

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Therapeutic oligonucleotides are chemically modified to enhance their drug-like properties - including binding affinity for target RNA. Many nucleic acid analogs that enhance RNA binding affinity constrain the furanose sugar in an RNA-like sugar pucker. The improvements in binding affinity result primarily from increased off-rates with minimal effects on on-rates for hybridization. To identify alternate chemical modification strategies that can modulate on- and off-rates for oligonucleotide hybridization, we hypothesized that extending conformational restraint across multiple nucleotides could modulate hybridization kinetics by restricting rotational freedom of the sugar-phosphate backbone. As part of that effort, we recently reported that using hydrocarbon tethers to bridge adjacent phosphodiester linkages as phosphonate tethered bridges can pre-organize nucleic acids in conformations conducive for Watson-Crick base-pairing and modulate hybridization kinetics. In this report, we describe the synthesis of locked nucleic acid (LNA) trimers linked through alkylphosphonate tethers which restrict conformation of the furanose sugar in addition to restricting conformational mobility of the sugar-phosphate backbone across three nucleotide units.

Identifiers

PMID39070250
PMCPMC11276400

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.